The Association for Molecular Pathology (AMP) is committed to the advancement of clinical molecular diagnostic and prognostic medicine through education and training of practitioners, physicians, laboratory and industrial scientists, and health care professionals involved in patient care and management. AMP supports the development of new technologies in molecular biology to be used in laboratory medicine, including diagnosis, treatment, and prognosis of genetic disorders, cancer, infectious diseases, identity and histocompatibility. AMP members and supporters participate in basic and translational research aimed at broadening the understanding of gene/protein structure and function, disease processes, and molecular diagnostics. AMP informs and educates its members of advances in, and applications of, nucleic acid-based diagnostics through its annual society meetings, publications, listserv, and other venues.

Individuals interested in the educational, medical, scientific, economic, and regulatory aspects of molecular diagnostics, including but not limited to pathologists, clinical laboratory scientists, clinicians and other health care personnel, government employees, especially those involved in regulation of the field, and professionals in the in vitro diagnostics industry, are invited to apply for membership.*

>>Go to Regular Membership Application
>>Go to Emeritus Membership Application
- Subscription to The Journal of Molecular Diagnostics (print and online)**
- AMP Annual Meeting on Genomic Medicine – the member discount nearly pays for your dues!
- CHAMP 2.0, (CHat AMP) – AMP member’s online community for discussions, networking, assay development advice, policy updates and other member-generated content!
- AMP Continuing Education – reduced fees or privileged access
      -  JMD CME Program in Molecular Diagnostics 
      -  Molecular Genetic Pathology Review Course
      -  Molecular Pathology Webinars
- Advocacy – with federal lawmakers and regulators on issues directly impacting molecular pathology test development and practice
- AMP Membership Directory – a valuable networking resource!
- AMP Test Directory - Members-only test submission privileges to this public online listing of molecular tests
- Trainees receive opportunities for mentoring from the broader membership:
      -  Further discounted annual meeting registration
      -  Junior membership on committees
- Members-only Awards to enhance your career
- Complimentary subscription to ADVANCE for Administrators of the Laboratory
 
Journal CME Program (Optional) 
The American Society for Investigative Pathology offers a journal-based CME program for The Journal of Molecular Diagnostics.  
 
The Journal of Molecular Diagnostics
The ASIP Semiannual 2012 JMD CME Program in Molecular Diagnostics is a semiannual program consisting of a series of at least 24 questions based on selected articles in the January – May 2012 issues (Volume 14 Numbers 1-3) of The Journal of Molecular Diagnostics (JMD). Bimonthly exams, consisting of at least 8 questions that are based on selected articles appearing in each issue of the Journal, will be available online on the Journal website for registered participants. To receive CME credit for this journal-based CME activity, participants must achieve a score of at least 75% on each bimonthly exam and complete a Post-Test Evaluation. All exams must be completed by June 30, 2012 to receive CME credit. Participants will earn 8 AMA PRA Category 1 Credit(s)™ for successful completion of each exam.  $150.00 (AMP Member rate) for 2012.
 
 
 
* AMP reserves the right to activate or inactivate memberships, in accordance with the AMP Bylaws and AMP Operating Procedures.

**AMP Members who have accepted the special HINARI membership or Emeritus annual dues rate receive online-only access to The Journal of Molecular Diagnostics.
 
Please be advised that 0.03% of the dues paid during 2010 were related to lobbying expenditures and are non-deductible pursuant to Internal Revenue Service Code section 162(e)(1). Please consult your tax advisor regarding your individual reporting requirements.